Saturn V Capital Management »

Inozyme Pharma shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.1M 1.1M 4.46

More positions owned by Saturn V Capital Management

Argenx Se Sponsored Adr (ARGX)
Disc Medicine (IRON)
Crinetics Pharmaceuticals In (CRNX)
Vaxcyte (PCVX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Cytokinetics Com New (CYTK)
BioMarin Pharmaceutical (BMRN)
Cogent Biosciences (COGT)
Cargo Therapeutics (CRGX)
Kalvista Pharmaceuticals (KALV)
Celcuity (CELC)
Merus N V (MRUS)
Syndax Pharmaceuticals (SNDX)
Abivax Sa Sponsored Ads (ABVX)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Saturn V Capital Management

Top funds holding Inozyme Pharma

Pivotal bioVenture Partners Investment Advisor
Sofinnova Ventures
Eventide Asset Management
Rock Springs Capital Management
Samlyn Capital
BlackRock
Affinity Asset Advisors
Vanguard Group
NEA Management Company
Millennium Management
Samsara BioCapital
Sphera Funds Management
Geode Capital Management
Saturn V Capital Management
Blue Owl Capital Holdings

View all funds holding Inozyme Pharma